Skip to content
Menu
Wicked Sister
Wicked Sister

Month: November 2025

Drowning In Life

Posted on November 19, 2025 by

Happy Midweek, y’all! I hope you are having a good week. Once we are at the halfway point of the week, the weekend is getting closer, and the last part of the week should be easier to get through. During the first half of your week, what was the best part for you? I will try to…

+

Holiday Wellness Bingo Card

Posted on November 19, 2025 by

By Stacie Prada Each year, the holiday season is a time of increased tasks, deadlines, and obligations. It can be stressful doing everything I need and want to do. Add managing my health issues with multiple sclerosis, and it can … Continue reading → Source: blog.mymsaa.org

+

MOGAD has unique immune signature distinct from MS: Study

Posted on November 18, 2025 by

Multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study found. These findings help explain why treatments approved for MS generally show limited effectiveness for MOGAD, researchers said. “These findings support MOGAD as its own disease entity, distinct from other…

+

A quiet truce after an MS relapse is like letting go, not fighting harder

Posted on November 18, 2025 by

November feels like an inhale that hasn’t yet decided whether to sigh or sing. The mornings are quieter now, the air cooler, and for the first time in months, I also feel more peaceful. On the other side of a recent relapse with relapsing-remitting multiple sclerosis, facing trauma head-on, a change of address, and a…

+

FDA approves generic version of Vumerity for relapsing MS

Posted on November 18, 2025 by

Zydus Lifesciences received final approval from the U.S. Food and Drug Administration (FDA) to market a generic version of Vumerity (diroximel fumarate) for adults with relapsing forms of multiple sclerosis (MS) and other conditions. The drug will be sold as 231 mg delayed-release capsules, produced at Zydus’s manufacturing facility in Ahmedabad, India, according to a…

+

Mesenchymal stem cell therapy shows promise for MS: Review

Posted on November 17, 2025 by

Mesenchymal stem cell therapy shows promise for treating multiple sclerosis (MS), with improvements seen in disability, walking ability, vision, and auditory function, according to a recent review of published studies. The approach also seems to be well tolerated by people with MS, but more research is needed on its long-term safety and efficacy, researchers noted….

+

Thankfulness and gratitude: Finding joy in Thanksgiving with MS

Posted on November 17, 2025 by

As Thanksgiving approaches, I find myself reflecting on what gratitude really means. Living with multiple sclerosis (MS) has taught me that thankfulness isn’t just about the big, joyful milestone moments; it’s about noticing and appreciating the small victories that make each day possible. The truth is, life with MS doesn’t pause for the holidays. My…

+

Ways To Spread Happiness & Kindness

Posted on November 17, 2025 by

Happy Monday, y’all! I hope you had a wonderful and relaxing weekend! We are back to the start of another week, but it does not need to be something we dread or fear; we should instead view it as a new opportunity. Of course, I know it is not easy, but I also know we…

+

Recharge, Reset, Restore: The Power of Restful Sleep

Posted on November 17, 2025 by

As the days grow shorter and our schedules seem to fill up faster, many of us forget one of the most restorative acts of self-care available to us, a good night’s sleep. While we often think of wellness in terms … Continue reading → Source: blog.mymsaa.org

+

My Bad …Trial Reporting

Posted on November 17, 2025 by

Tweet If a trial is a success and you are going somewhere there is a desire to play by the rules but if your trial has failed then there is little incentive to have to report stuff Cwajna M, Hamouda AM, Kendall N, Ghozy S, Atieh F, Aboseif A, Ahmed NS, Kallmes DF, Arumaithurai K,…

+
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next

Recent Posts

  • Anti-Alemtuzumab antibodies
  • Chronic inflammation signals brain atrophy in children with MS: Study
  • The Reality of Living with SPMS
  • Why I’m researching clinical trials as I prepare to switch my DMT
  • Holiday Rice Krispie Treats

Recent Comments

    Archives

    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • February 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • July 2019

    Categories

    • Multiple Sclerosis Research
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    NAVBAR

    Archive 1

    MS Search

    Recent

      ©2025 Wicked Sister | Powered by Superb Themes